ABDELMOUMAN GHOUMARI,BARTOSZ BIELECKI,MICHAEL MARIA SCHUMACHER,RASHAD HUSSAIN,REGINE SITRUK-WARE,SAID GHANDOUR
申请号：
BR112013024084
公开号：
BR112013024084A2
申请日:
2012.03.22
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
Methods for effective remyelination in patients are disclosed comprising treating the patient with an androgen receptor ligand which exerts binding to androgen receptors and elicits androgen-receptor-induced biological responses at a dosage sufficient to induce remyelination. The androgen compound preferably comprises MENT in an androgen targeting both androgen and estrogen receptors, and the methods include combining the androgen compound with a progestin compound in order to provide both contraception in men and treatment for neurodegeneration.
